Clinical Trial Update: Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of oral LW402 tablets in adults with moderate-to-severe atopic dermatitis; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LW402

Snippet

Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. | Conditions: Moderate to Severe Atopic Dermatitis | Phase 3 | Status: NOT_YET_RECRUITING